PTC Therapeutics reported $4.43B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 33.38B 1.48B Sep/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Cytokinetics USD 7.51B 1.66B Nov/2026
Daiichi Sankyo JPY 5.22T 356.74B Sep/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 184.82B 27.96B Sep/2026
Incyte USD 24.6B 1.95B Sep/2026
Ionis Pharmaceuticals USD 4.24B 3.18B Nov/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Novartis USD 292.09B 51.5B Sep/2026
Pfizer USD 165.12B 1.71B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
TG Therapeutics USD 10B 1.46B Nov/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026
Xencor USD 2.14B 281M Nov/2026